SEC Form 4 · accession 0001642833-17-000001
Evolent Health, Inc. · EVH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Weinberg
Officer — General Counsel
Period of report
May 3, 2017
Accepted (ET)
May 5, 2017 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628908
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | May 3, 2017 | M | 15,000 | $3.84 | A | 86,385 | D | |
| Class A Common StockF2 | May 3, 2017 | S | 15,000 | $23.85 | D | 71,385 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Option (right to buy)F3 | $3.84 | May 3, 2017 | M | 15,000 | D | — | Apr 1, 2024 | Class A Common Stock | 15,000 | 102,661 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2017.
- F2The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $23.85-$23.875, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The Class A Common Stock Options exercised vested on February 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on April 1, 2014 vested on February 1, 2015; the balance vested or vests in equal installments annually over the following three years.